Growth Metrics

Integra Lifesciences Holdings (IART) Cash from Operations Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.78%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 9.30%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 20.35%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 22.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -48.14%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.50%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 50.11%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -14.75%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.83%
10 Integra Lifesciences Holdings 1.20 Bn 939.16 Mn 216.98 Mn -27.90%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -27.90%
Dec 31, 2025 -48.27%
Sep 30, 2025 -15.71%
Jun 30, 2025 -48.81%
Mar 31, 2025 -31.11%
Dec 31, 2024 -9.86%
Sep 30, 2024 -35.24%
Jun 30, 2024 -23.79%
Mar 31, 2024 -38.90%
Dec 31, 2023 -9.88%
Sep 30, 2023 -27.29%
Jun 30, 2023 -5.13%
Mar 31, 2023 7.91%
Dec 31, 2022 -1.46%
Sep 30, 2022 2.07%
Jun 30, 2022 11.06%
Mar 31, 2022 14.57%
Dec 31, 2021 17.52%
Sep 30, 2021 1.46%
Jun 30, 2021 36.10%
Mar 31, 2021 18.48%
Dec 31, 2020 90.83%
Sep 30, 2020 15.46%
Jun 30, 2020 4.68%
Mar 31, 2020 -10.34%
Dec 31, 2019 139.05%
Sep 30, 2019 11.16%
Jun 30, 2019 8.42%
Mar 31, 2019 5.61%
Dec 31, 2018 18.52%
Sep 30, 2018 59.28%
Jun 30, 2018 -3.42%
Mar 31, 2018 9.52%
Dec 31, 2017 39.67%
Sep 30, 2017 13.34%
Jun 30, 2017 20.80%
Mar 31, 2017 36.91%
Dec 31, 2016 -17.12%
Sep 30, 2016 14.93%
Jun 30, 2016 135.43%
Mar 31, 2016 47.21%
Dec 31, 2015 112.05%
Sep 30, 2015 -11.10%
Jun 30, 2015 160.41%
Mar 31, 2015 -0.73%
Dec 31, 2014 -50.38%
Sep 30, 2014 9.31%
Jun 30, 2014 -12.66%
Mar 31, 2014 -19.10%
Dec 31, 2013 -26.11%
Sep 30, 2013 1.29%
Jun 30, 2013 -46.78%
Mar 31, 2013 -34.67%
Dec 31, 2012 -27.49%
Sep 30, 2012 -0.54%